دورية أكاديمية
EP10.01-011 Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab
| العنوان: | EP10.01-011 Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab |
|---|---|
| المؤلفون: | Trestini, I., Cintoni, M., Caldart, A., Dodi, A., Sposito, M., Kadrija, D., Belluomini, L., Menis, J., Vita, E., Sperduti, I., Drudi, A., Aluffi, G., Todesco, M., Tregnago, D., Avancini, A., D'Onofrio, M., Mele, M.C., Tortora, G., Milella, M., Bria, E., Pilotto, S. |
| المصدر: | Journal of Thoracic Oncology ; volume 17, issue 9, page S504-S505 ; ISSN 1556-0864 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.jtho.2022.07.888 |
| الإتاحة: | https://doi.org/10.1016/j.jtho.2022.07.888Test https://api.elsevier.com/content/article/PII:S1556086422012291?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1556086422012291?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.3BF95E8F |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.jtho.2022.07.888 |
|---|